139 filings
Page 3 of 7
8-K
q83x ssjrgi4hm
3 Aug 23
Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc
9:04am
8-K
7vouon6v87638y5uz
27 Jul 23
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
9:04am
EFFECT
exglgo f0
17 Jul 23
Notice of effectiveness
12:15am
424B3
w82h0118yp9
14 Jul 23
Prospectus supplement
4:16pm
CORRESP
h35wat
12 Jul 23
Correspondence with SEC
12:00am
CORRESP
asfxhi u0v1fmh2c
7 Jul 23
Correspondence with SEC
12:00am
UPLOAD
zqo82sts5a71zmkh94c
5 Jul 23
Letter from SEC
12:00am
8-K
3pfo7pcqs
26 Jun 23
Disrupting Convention in Women’s Health Through Continuous Innovation June 2023 Corporate Presentation 1
8:05am
8-K
rli0npvax60y29m
21 Jun 23
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
r6px7l6ctympz
15 Jun 23
Femasys Inc. Replaces Two Board Members with Seasoned Industry Leaders in the Life Sciences
8:23am
8-K
7hff8xz9wa
8 Jun 23
Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada
4:01pm
8-K
eovubnkvc mwpyb7
2 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:20pm
DEFA14A
6zu357 5yd9w04
16 May 23
Additional proxy soliciting materials
4:36pm
ARS
9xg48gtuu44cujymb
15 May 23
Annual report to shareholders
6:08am